Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Gasperini · SciRah

Researcher profile · Semantic Scholar

C. Gasperini

Share profile

C. Gasperini — researcher profile on SciRah

h-index: 64
Works: 418
Citations: 15K

Most-cited papers

2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis.
F. Barkhof, Daniel S. Reich, Jiwon Oh, M. Rocca +30 more
2025Lancet Neurology75 citations Open access
Semantic Scholar
Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis
Olga Ciccarelli, F. Barkhof, Massimiliano Calabrese, N. de Stefano +11 more
2024Neurology72 citations Open access
Semantic Scholar
The ageing central nervous system in multiple sclerosis: the imaging perspective
M. Filippi, P. Preziosa, F. Barkhof, O. Ciccarelli +14 more
2024Brain : a journal of neurology52 citations Open access
Semantic Scholar
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria
Á. Vidal-Jordana, À. Rovira, Willem Calderon, G. Arrambide +21 more
2023Neurology51 citations
Semantic Scholar
Multiple Sclerosis Progression and Relapse Activity in Children.
P. Iaffaldano, E. Portaccio, G. Lucisano, M. Simone +41 more
2023JAMA Neurology47 citations
Semantic Scholar
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
R. Cortese, M. Battaglini, F. Prados, A. Bianchi +43 more
2022Brain : a journal of neurology41 citations Open access
Semantic Scholar
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis
D. Landi, F. Bovis, Alfonso Grimaldi, P. Annovazzi +53 more
2022Journal of Neurology Neurosurgery & Psychiatry34 citations Open access
Semantic Scholar
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Damiano Baroncini, A. Ghezzi, C. Guaschino, L. Moiola +28 more
2022Neurological Sciences32 citations
Semantic Scholar
Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain
F. Gargano, G. Guerrera, Eleonora Piras, B. Serafini +22 more
2022Frontiers in Immunology30 citations Open access
Semantic Scholar
Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
A. Aiello, A. Coppola, V. Vanini, L. Petrone +14 more
2022International Journal of Infectious Diseases30 citations Open access
Semantic Scholar
The added value of spinal cord lesions to disability accrual in multiple sclerosis
S. Ruggieri, L. Prosperini, M. Petracca, A. Logoteta +5 more
2023Journal of Neurology29 citations Open access
Semantic Scholar
Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world context
L. Prosperini, S. Ruggieri, S. Haggiag, Carla Tortorella +1 more
2024Multiple Sclerosis28 citations Open access
Semantic Scholar
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies
L. Prosperini, S. Haggiag, S. Ruggieri, Carla Tortorella +1 more
2023CNS Drugs28 citations
Semantic Scholar
Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis
A. Lazzarotto, Mariem Hamzaoui, Matteo Tonietto, Anne-Laure Dubessy +13 more
2024Brain : a journal of neurology27 citations Open access
Semantic Scholar
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies
L. Prosperini, C. Tortorella, S. Haggiag, S. Ruggieri +2 more
2022Journal of Neurology26 citations Open access
Semantic Scholar
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody‐associated Disease, Aquaporin‐4 Antibody‐Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
R. Cortese, M. Battaglini, F. Prados, G. Gentile +43 more
2024Annals of Neurology25 citations Open access
Semantic Scholar
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
A. Buonomo, G. Viceconte, M. Calabrese, G. De Luca +25 more
2022Journal of Neurology25 citations Open access
Semantic Scholar
The influence of MOGAD on diagnosis of multiple sclerosis using MRI
Ruth Geraldes, G. Arrambide, Brenda Banwell, Á. Rovira +20 more
2024Nature Reviews Neurology24 citations Open access
Semantic Scholar
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
A. Aiello, A. Coppola, S. Ruggieri, C. Farroni +20 more
2022Journal of Neurology Neurosurgery & Psychiatry24 citations Open access
Semantic Scholar
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion
M. Filippi, M. Amato, C. Avolio, P. Gallo +4 more
2025Journal of Neurology21 citations Open access
Semantic Scholar
Prognostic value of single-subject grey matter networks in early multiple sclerosis
V. Fleischer, G. González-Escamilla, D. Pareto, À. Rovira +19 more
2023Brain : a journal of neurology19 citations Open access
Semantic Scholar
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
S. Ruggieri, L. Prosperini, S. Al-Araji, P. Annovazzi +24 more
2023Journal of Neurology Neurosurgery & Psychiatry18 citations
Semantic Scholar
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
M. Simone, G. Lucisano, T. Guerra, D. Paolicelli +21 more
2024Journal of Neurology16 citations Open access
Semantic Scholar
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus
M. Filippi, M. Amato, D. Centonze, P. Gallo +6 more
2025Journal of Neurology15 citations Open access
Semantic Scholar
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning
G. Pontillo, F. Prados, J. Colman, B. Kanber +56 more
2024Neurology14 citations Open access
Semantic Scholar
Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
D. Centonze, M. Amato, V. Brescia Morra, E. Cocco +6 more
2023Therapeutic Advances in Neurological Disorders13 citations Open access
Semantic Scholar
Patient-reported outcome measures in drugs for neurological conditions approved by European Medicines Agency 2017–2022
O. Ciani, Michela Meregaglia, M. Battaglia, G. Brichetto +3 more
2023Neurological Sciences13 citations Open access
Semantic Scholar
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
P. Mosconi, T. Guerra, Pasquale Paletta, A. D'Ettorre +151 more
2023Neurological Sciences11 citations Open access
Semantic Scholar
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis
F. J. Carod-Artal, P. Adjamian, Carlos Vila Silván, M. Bagul +1 more
2022Expert Review of Neurotherapeutics11 citations Open access
Semantic Scholar
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
S. Ruggieri, A. Aiello, C. Tortorella, A. Navarra +18 more
2023International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs
R. Capuano, L. Prosperini, M. Altieri, L. Lorefice +20 more
2023Multiple Sclerosis10 citations Open access
Semantic Scholar
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register
P. Iaffaldano, G. Lucisano, T. Guerra, F. Patti +32 more
2022Multiple Sclerosis10 citations
Semantic Scholar
Personalized therapy in multiple sclerosis: an Italian Delphi consensus
C. Gasperini, D. Centonze, A. Conte, P. Gallo +5 more
2025Journal of Neurology9 citations Open access
Semantic Scholar
Brain reserve and timing of clinical onset in multiple sclerosis
M. Petracca, S. Ruggieri, Riccardo Nistri, Ilaria Tomasso +7 more
2024Multiple Sclerosis9 citations
Semantic Scholar
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
P. Iaffaldano, G. Lucisano, T. Guerra, F. Patti +64 more
2023Journal of Neurology9 citations
Semantic Scholar
Signs and symptoms of COVID‐19 in patients with multiple sclerosis
I. Schiavetti, L. Carmisciano, M. Ponzano, C. Cordioli +255 more
2022European Journal of Neurology9 citations Open access
Semantic Scholar
Are mechanical thrombectomy or thrombolysis universally cost-effective? A systematic review of the literature.
G. de Rubeis, S. Fabiano, L. Bertaccini, A. Wlderk +5 more
2022World Neurosurgery9 citations
Semantic Scholar
User requirements for quantitative radiological reports in multiple sclerosis
D. V. van Nederpelt, Zoe Mendelsohn, Lonneke Bos, Rozemarijn M. Mattiesing +22 more
2025European Radiology8 citations Open access
Semantic Scholar
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
P. Preziosa, M. Amato, L. Battistini, M. Capobianco +7 more
2024Journal of Neurology8 citations
Semantic Scholar
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody–Associated Disease
R. Cortese, F. Sforazzini, G. Gentile, Anna de Mauro +50 more
2025Neurology6 citations Open access
Semantic Scholar
Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE
R. Hupperts, C. Gasperini, J. Lycke, T. Ziemssen +5 more
2022Therapeutic Advances in Neurological Disorders6 citations Open access
Semantic Scholar
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies.
Viviana Nociti, Marina Romozzi, P. Annovazzi, R. Fantozzi +16 more
2025Journal of Neurological Sciences5 citations
Semantic Scholar
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS
S. Haggiag, L. Prosperini, Massimo Filippi, M. Rocca +83 more
2025JAMA Network Open5 citations Open access
Semantic Scholar
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience
S. Ruggieri, A. Ianniello, M. Copetti, Marta Altieri +18 more
2024Neurotherapeutics5 citations Open access
Semantic Scholar
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trials
Valeria Pozzilli, S. Haggiag, M. Di Filippo, F. Capone +4 more
2024Journal of Neurology Neurosurgery & Psychiatry5 citations
Semantic Scholar
Unveiling preferences in multiple sclerosis care: insights from an Italian discrete-choice experiment with patients and healthcare professionals
C. Gasperini, M. A. Battaglia, Federica Balzani, E. Chiarini +4 more
2024Journal of Neurology5 citations Open access
Semantic Scholar
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study
C. Chisari, U. Aguglia, M. Amato, R. Bergamaschi +64 more
2024Neurotherapeutics5 citations Open access
Semantic Scholar
Dimethyl Fumarate or Teriflunomide for Relapsing–Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing Studies
L. Prosperini, S. Haggiag, S. Ruggieri, C. Tortorella +1 more
2023Neurotherapeutics5 citations Open access
Semantic Scholar
Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion
P. Preziosa, V. Brescia Morra, M. Capobianco, C. Gasperini +6 more
2025Journal of Neurology4 citations Open access
Semantic Scholar
Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-CD20 Monoclonal Antibodies for Multiple Sclerosis Treatment
M. Margoni, L. Battistini, D. Centonze, R. Furlan +2 more
2025Current Neuropharmacology4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Ruggieri×19
Invite
S. Ruggieri — researcher profile on SciRah
Carla Tortorella×14
Invite
Carla Tortorella — researcher profile on SciRah
C. Pozzilli×14
Invite
C. Pozzilli — researcher profile on SciRah
N. de Stefano×13
Invite
N. de Stefano — researcher profile on SciRah

×13

Invite

M. Filippi — researcher profile on SciRah

L. Prosperini×13

Invite

L. Prosperini — researcher profile on SciRah

V. Brescia Morra×12

Invite

V. Brescia Morra — researcher profile on SciRah

Invite

G. De Luca — researcher profile on SciRah

J. Sastre-Garriga×11

Invite

J. Sastre-Garriga — researcher profile on SciRah

Invite

M. Trojano — researcher profile on SciRah

D. Paolicelli×10

Invite

D. Paolicelli — researcher profile on SciRah

Invite

F. Patti — researcher profile on SciRah